$190.00
FOXO4 10mg is a research peptide, commonly known as FOXO4-DRI or Proxofim, studied for its role in FOXO4-p53 interaction, cellular senescence, and ageing-related research pathways. For research use only.
FOXO4 10mg, commonly listed as FOXO4-DRI or Proxofim, is a synthetic research peptide used in laboratory studies involving cellular senescence, FOXO4-p53 signalling, ageing-related pathways, and apoptosis research. FOXO4-DRI is described as a cell-permeable peptide antagonist that blocks the interaction between FOXO4 and p53, a mechanism studied for its potential role in selectively targeting senescent cells.
CAS No.: 2460055-10-9
This product is intended for laboratory research use only and is not for human consumption, clinical use, veterinary use, or diagnostic applications.